Bayview Pharmacy is pleased to present a specialized compounded formulation of Phenobarbital 16.2 mg, Hyoscyamine Sulfate 0.1037 mg, Atropine Sulfate 0.0194 mg, and Scopolamine HBr 0.0065 mg in capsule form. These capsules are solid dosage forms composed of two gelatin or vegetarian shells that enclose the medication. This design allows for easy swallowing and ensures a precise dosage of the active ingredients.

This unique formulation is intended to address a range of conditions, including irritable bowel syndrome, urinary incontinence, and motion sickness. Each component of this formulation plays a crucial role in symptom management. Phenobarbital, an anticonvulsant and sedative, aids in reducing muscle spasms and promoting relaxation. Hyoscyamine Sulfate and Atropine Sulfate, both anticholinergics, work to alleviate abdominal cramping, spasms, and excessive secretions. Scopolamine HBr, another anticholinergic, is effective in reducing nausea and vomiting.

This comprehensive formulation offers an effective treatment strategy for various disease states, particularly in managing symptoms associated with irritable bowel syndrome, urinary incontinence, and motion sickness. It is crucial to remember that this formulation should be used strictly under the guidance of a healthcare professional. If you have any queries or require further information about this formulation, please do not hesitate to contact us at Bayview Pharmacy.

This compounded formulation of Phenobarbital 16.2 mg, Hyoscyamine Sulfate 0.1037 mg, Atropine Sulfate 0.0194 mg, and Scopolamine HBr 0.0065 mg is encapsulated within two gelatin or vegetarian shells. This design allows for easy swallowing and ensures a precise dosage of the active ingredients. The formulation is primarily used in the treatment of various conditions such as irritable bowel syndrome, peptic ulcer disease, and motion sickness.

It is crucial for patients to be aware that this formulation may interact with other medications, including but not limited to anticholinergics, anticonvulsants, and sedatives. Therefore, it is highly recommended that patients inform their healthcare provider of any other medications they are currently taking before starting this treatment.

Patients should also be aware of the potential side effects of this formulation, which may include drowsiness, blurred vision, dry mouth, and constipation. It is advised that patients refrain from driving or operating heavy machinery until they fully understand how this formulation affects them. Furthermore, this formulation may interact with alcohol and other substances, and their use should be avoided while on this medication.

If you have any questions or concerns about this formulation, it is recommended that you consult with your healthcare provider or pharmacist for further information and guidance.

Phenobarbital 16.2 mg/Hyoscyamine Sulfate 0.1037 mg/Atropine Sulfate 0.0194 mg/Scopolamine HBr 0.0065 mg Capsules is a compounded formulation of four active ingredients, each playing a crucial role in managing a variety of conditions such as irritable bowel syndrome, peptic ulcer disease, and motion sickness. This medication works by blocking the action of certain chemicals in the body that can cause spasms and other symptoms, thereby reducing the severity of these symptoms and providing relief.

Phenobarbital, an anticonvulsant, helps to reduce muscle spasms and relax the muscles. Hyoscyamine sulfate, an anticholinergic, aids in reducing stomach acid and relaxing the muscles of the digestive tract. Similarly, Atropine sulfate, another anticholinergic, works to reduce stomach acid and relax the muscles of the digestive tract. Lastly, Scopolamine HBr, also an anticholinergic, contributes to reducing stomach acid and relaxing the muscles of the digestive tract.

When taken as directed, this combination medication can significantly reduce the severity of symptoms associated with the aforementioned conditions. It is crucial to take this medication exactly as prescribed by your healthcare provider. Do not alter the dosage without consulting your doctor. Abruptly stopping this medication can lead to withdrawal symptoms, hence it is advised to gradually decrease the dose under the supervision of your healthcare provider. If you have any questions or concerns about this medication, please consult your healthcare provider or pharmacist.

This compounded formulation of Phenobarbital 16.2 mg/Hyoscyamine Sulfate 0.1037 mg/Atropine Sulfate 0.0194 mg/Scopolamine HBr 0.0065 mg Capsules is encased in two gelatin or vegetarian shells. This design allows for easy swallowing and ensures a precise dosage of the active ingredients. The medication is versatile and can be used to treat a variety of conditions. It may be used in the management of Parkinson’s disease, seizures, and spasticity. It can also be beneficial in reducing the symptoms of opioid withdrawal and lowering the risk of opioid overdose. This formulation may also be effective in treating certain types of headaches, including cluster headaches and migraines. It can be used to manage certain types of anxiety disorders, such as panic disorder and generalized anxiety disorder. Furthermore, it may be beneficial in treating certain types of depression, including major depressive disorder and bipolar disorder. If you have any questions about the use of this formulation for any of these conditions, please reach out for further information.